Immunovant Sciences Gmbh

This study tests a drug called batoclimab in 240 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if it can improve daily activities and reduce symptoms. Participants receive either the drug or a placebo as a shot under the sk…

This study looks at the long-term safety and effectiveness of an investigational drug called IMVT-1402 for adults with Graves' disease, a condition where the immune system attacks the thyroid. Participants who completed earlier studies will be assigned to one of three groups base…

This study looks at the long-term safety of a drug called batoclimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition that causes weakness and numbness. About 108 people who completed a previous study will get weekly injections for up to a yea…

This study tests a new drug called IMVT-1402 in 120 adults with active, difficult-to-treat rheumatoid arthritis (RA) who have a specific antibody (ACPA-positive). The goal is to see if the drug can help control the disease and reduce joint pain and swelling. Participants will rec…